Centessa Pharmaceuticals plc
CNTA
$29.07
$0.561.96%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -242.70M | -230.37M | -223.85M | -235.76M | -161.27M |
| Total Depreciation and Amortization | 770.00K | 769.00K | 779.00K | 802.00K | 814.00K |
| Total Amortization of Deferred Charges | 1.02M | 745.00K | 452.00K | 140.00K | 144.00K |
| Total Other Non-Cash Items | 66.18M | 67.75M | 67.70M | 70.60M | 36.45M |
| Change in Net Operating Assets | -6.07M | 17.22M | -7.10M | 22.16M | -6.45M |
| Cash from Operations | -180.81M | -143.89M | -162.02M | -142.06M | -130.31M |
| Capital Expenditure | -360.00K | -160.00K | -34.00K | -34.00K | -62.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -175.04M | -192.22M | -207.85M | 31.30M | -11.95M |
| Cash from Investing | -175.40M | -192.38M | -207.88M | 31.27M | -12.01M |
| Total Debt Issued | 109.34M | 109.34M | 109.34M | 109.34M | -- |
| Total Debt Repaid | -110.10M | -110.10M | -110.10M | -110.10M | -- |
| Issuance of Common Stock | 18.45M | 261.84M | 368.21M | 370.83M | 371.88M |
| Repurchase of Common Stock | -4.62M | -5.46M | -3.73M | -3.73M | -3.73M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.98M | -1.98M | -6.37M | -1.59M | -- |
| Cash from Financing | 11.09M | 253.64M | 357.35M | 364.75M | 368.15M |
| Foreign Exchange rate Adjustments | 901.00K | -502.00K | -509.00K | 1.23M | -2.31M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -344.22M | -83.13M | -13.06M | 255.19M | 223.53M |